Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy

Overview of attention for article published in Journal of Clinical Investigation, February 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 38 X users

patent: 3 patents

Readers on

mendeley: 122 Mendeley

So far, Altmetric has seen 3 patents that reference this research output.

Methods and materials for treating cancer

Grant US-12527851-B2

United States of America

SALT NANOPARTICLES AND COMPOSITIONS AND METHODS OF USE THEREOF

Application EP-3911361-A4

European Patent Office

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-TARGETED ADJUVANTS

Application WO-2020247973-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.